A detailed history of Caprock Group, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Caprock Group, Inc. holds 46,512 shares of BSX stock, worth $4.2 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
46,512
Previous 42,826 8.61%
Holding current value
$4.2 Million
Previous $3.3 Million 18.16%
% of portfolio
0.14%
Previous 0.14%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$72.96 - $84.0 $268,930 - $309,624
3,686 Added 8.61%
46,512 $3.9 Million
Q2 2024

Aug 06, 2024

BUY
$67.33 - $77.71 $1.1 Million - $1.27 Million
16,348 Added 61.74%
42,826 $3.3 Million
Q1 2024

Apr 29, 2024

SELL
$57.6 - $68.62 $1,958 - $2,333
-34 Reduced 0.13%
26,478 $1.81 Million
Q4 2023

Jan 18, 2024

BUY
$48.64 - $57.81 $68,922 - $81,916
1,417 Added 5.65%
26,512 $1.53 Million
Q3 2023

Oct 18, 2023

SELL
$50.19 - $54.68 $27,253 - $29,691
-543 Reduced 2.12%
25,095 $1.33 Million
Q2 2023

Aug 10, 2023

BUY
$49.72 - $54.64 $90,987 - $99,991
1,830 Added 7.69%
25,638 $1.39 Million
Q1 2023

Apr 26, 2023

BUY
$45.09 - $50.03 $150,465 - $166,950
3,337 Added 16.3%
23,808 $1.19 Million
Q4 2022

Jan 23, 2023

BUY
$39.56 - $47.22 $100,403 - $119,844
2,538 Added 14.15%
20,471 $0
Q3 2022

Nov 07, 2022

BUY
$36.71 - $109.66 $54,697 - $163,393
1,490 Added 9.06%
17,933 $695,000
Q2 2022

Jul 26, 2022

BUY
$35.24 - $47.1 $65,863 - $88,029
1,869 Added 12.82%
16,443 $613,000
Q1 2022

Apr 12, 2022

BUY
$40.9 - $45.1 $176,401 - $194,516
4,313 Added 42.03%
14,574 $645,000
Q4 2021

Jan 18, 2022

BUY
$38.07 - $44.87 $45,912 - $54,113
1,206 Added 13.32%
10,261 $436,000
Q3 2021

Oct 07, 2021

BUY
$41.23 - $45.88 $5,937 - $6,606
144 Added 1.62%
9,055 $393,000
Q2 2021

Aug 13, 2021

SELL
$38.58 - $44.24 $87,615 - $100,469
-2,271 Reduced 20.31%
8,911 $381,000
Q1 2021

Apr 29, 2021

BUY
$35.27 - $39.67 $128,700 - $144,755
3,649 Added 48.44%
11,182 $432,000
Q4 2020

Jan 29, 2021

SELL
$33.15 - $41.97 $122,323 - $154,869
-3,690 Reduced 32.88%
7,533 $271,000
Q3 2020

Oct 29, 2020

BUY
$34.44 - $42.23 $36,196 - $44,383
1,051 Added 10.33%
11,223 $429,000
Q2 2020

Aug 05, 2020

BUY
$30.19 - $39.11 $54,975 - $71,219
1,821 Added 21.81%
10,172 $357,000
Q1 2020

Apr 28, 2020

SELL
$25.83 - $45.71 $59,176 - $104,721
-2,291 Reduced 21.53%
8,351 $272,000
Q4 2019

Feb 04, 2020

BUY
$37.87 - $45.37 $11,929 - $14,291
315 Added 3.05%
10,642 $481,000
Q3 2019

Oct 31, 2019

SELL
$40.31 - $43.45 $3,386 - $3,649
-84 Reduced 0.81%
10,327 $420,000
Q2 2019

Jul 23, 2019

SELL
$34.91 - $42.98 $84,447 - $103,968
-2,419 Reduced 18.85%
10,411 $447,000
Q1 2019

Apr 12, 2019

BUY
$32.91 - $40.75 $20,864 - $25,835
634 Added 5.2%
12,830 $492,000
Q4 2018

Jan 29, 2019

BUY
$31.73 - $39.04 $31,127 - $38,298
981 Added 8.75%
12,196 $431,000
Q3 2018

Oct 17, 2018

BUY
$32.83 - $38.63 $3,020 - $3,553
92 Added 0.83%
11,215 $432,000
Q2 2018

Jul 23, 2018

BUY
$26.84 - $34.32 $298,541 - $381,741
11,123 New
11,123 $364,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Caprock Group, Inc. Portfolio

Follow Caprock Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.